1. | 387368dman | |
2. | kitcaitrn | |
3. | jeepmagick | |
4. | matthewsmelt6 | |
5. | jil4411 |
1. | 387368dman | |
2. | kitcaitrn | |
3. | jeepmagick | |
4. | matthewsmelt6 | |
5. | jil4411 |
1. | jeepmagick 06/18/2018 Good reason to feel good. |
2. | 387368dman 02/12/2018 Cantor Fitzgerald raises price target to $5 from $2 |
3. | matthewsmelt6 06/18/2018 Arrowhead Pharmaceuticals (ARWR): Speedy ARO-AAT Enrollment Signals Catalysts to Come, Says Cantor |
4. | kitcaitrn 02/09/2018 Misses EPS loss estimates by $0.02 and misses on revenues |
5. | 387368dman 02/22/2018 Receives regulatory clearance to begin Phase 1 Study of ARO-AAT for treatment of Alpha-1 Liver disease |
6. | jil4411 06/29/2018 Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference |
7. | matthewsmelt6 03/27/2018 Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B |
8. | jeepmagick 02/15/2018 Receives regulatory clearance to begin Phase 1/2 study of ARO=HBV for treatment of Hepatitis B |
9. | 387368dman 05/21/2018 Presents new data on ARO-ENaC |
10. | kitcaitrn 02/15/2018 Granted orphan drug designation |